statistiche ricercatore

Continente	#
NA - Nord America	1.098
EU - Europa	541
AS - Asia	469
Continente sconosciuto - Info sul continente non disponibili	74
SA - Sud America	50
AF - Africa	11
OC - Oceania	1
Totale	2.244

Nazione	#
US - Stati Uniti d'America	1.071
SG - Singapore	215
IT - Italia	155
CN - Cina	108
IE - Irlanda	73
SE - Svezia	57
VN - Vietnam	53
DE - Germania	50
RU - Federazione Russa	47
GB - Regno Unito	44
BR - Brasile	37
IN - India	30
UA - Ucraina	30
TR - Turchia	26
FR - Francia	24
AT - Austria	17
CA - Canada	12
HK - Hong Kong	9
FI - Finlandia	8
PL - Polonia	7
BD - Bangladesh	6
JP - Giappone	6
LT - Lituania	6
MX - Messico	5
NL - Olanda	5
AR - Argentina	4
ZA - Sudafrica	4
BE - Belgio	3
CO - Colombia	3
MA - Marocco	3
SV - El Salvador	3
CL - Cile	2
EC - Ecuador	2
EE - Estonia	2
GR - Grecia	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
MY - Malesia	2
NO - Norvegia	2
PA - Panama	2
UZ - Uzbekistan	2
AL - Albania	1
BG - Bulgaria	1
BY - Bielorussia	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DZ - Algeria	1
ES - Italia	1
ID - Indonesia	1
IL - Israele	1
KR - Corea	1
KW - Kuwait	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LV - Lettonia	1
NG - Nigeria	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PE - Perù	1
PK - Pakistan	1
PR - Porto Rico	1
RS - Serbia	1
SA - Arabia Saudita	1
SC - Seychelles	1
SR - Suriname	1
TT - Trinidad e Tobago	1
Totale	2.171

Nome	#
(R)-Î±-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease	197
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma	180
Advances in prodrug design for Parkinson's disease	178
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents	173
NSAID Coniugates for the treatment of Alzheimer's Disease	172
Carvacrol prodrugs as novel antimicrobial agents	167
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease	165
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties	165
Synthesis and antioxidant properties of novel memantine derivatives	164
Nano-delivery systems based on carvacrol prodrugs and fibrous clays	161
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay	135
Carvacrol prodrugs with antimicrobial activity loaded on clay nanocomposites	134
Early life exposure to permethrin: a progressive animal model of Parkinson's disease	132
Potential anticancer effect of carvacrol codrugs on human glioblastoma cells	121
Totale	2.244

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	93	0	0	0	0	14	7	13	7	9	7	7	29
2022/2023	303	26	55	21	39	20	50	14	35	27	1	9	6
2023/2024	135	10	1	10	6	10	60	24	4	0	2	1	7
2024/2025	301	18	61	61	16	1	25	1	14	25	5	39	35
2025/2026	660	55	22	51	100	93	40	97	43	59	54	23	23
2026/2027	274	10	48	39	121	56	0	0	0	0	0	0	0
Totale													2.244